Search research articles
Contact Us
Filters
Showing results (191-200 of 240) with videos related to
Page
of 24
Sort By:
Bone Marrow Transplantation
|
November 13, 2021
Correction to: Salvage treatment with plerixafor in poor mobilizing allogeneic stem cell donors: results of a prospective phase II-trial
Kristina Hölig, Helmuth Schmidt, Gero Hütter, et al.
Frontiers in Immunology
|
October 31, 2022
Perturbations of mesenchymal stromal cells after allogeneic hematopoietic cell transplantation predispose for bone marrow graft-versus-host-disease
Thomas Krüger, Rebekka Wehner, Maik Herbig, et al.
The Lancet. Haematology
|
March 19, 2018
Long-term efficacy of reduced-intensity versus myeloablative conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: retrospective follow-up of an open-label, randomised phase 3 trial
Frederick Fasslrinner, Johannes Schetelig, Andreas Burchert, et al.
Lancet (London, England)
|
December 7, 2010
Complete remission and early death after intensive chemotherapy in patients aged 60 years or older with acute myeloid leukaemia: a web-based application for prediction of outcomes
Utz Krug, Christoph Röllig, Anja Koschmieder, et al.
Bone Marrow Transplantation
|
October 8, 2020
Salvage treatment with plerixafor in poor mobilizing allogeneic stem cell donors: results of a prospective phase II-trial
Kristina Hölig, Helmuth Schmidt, Gero Hütter, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
November 10, 2015
Allogeneic Stem Cell Transplantation Improves Survival in Patients with Acute Myeloid Leukemia Characterized by a High Allelic Ratio of Mutant FLT3-ITD
Anthony D Ho, Johannes Schetelig, Tilmann Bochtler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 2013
High-dose cytarabine consolidation with or without additional amsacrine and mitoxantrone in acute myeloid leukemia: results of the prospective randomized AML2003 trial
Markus Schaich, Stefani Parmentier, Michael Kramer, et al.
Nature Astronomy
|
July 26, 2022
Discovery of a radio emitting neutron star with an ultra-long spin period of 76 seconds
Manisha Caleb, Ian Heywood, Kaustubh Rajwade, et al.
The Journal of Clinical Investigation
|
September 13, 2022
Immune dysfunction signatures predict outcomes and define checkpoint blockade-unresponsive microenvironments in acute myeloid leukemia
Sergio Rutella, Jayakumar Vadakekolathu, Francesco Mazziotta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 12, 2012
Acute Myeloid Leukemia (AML): different treatment strategies versus a common standard arm--combined prospective analysis by the German AML Intergroup
Thomas Büchner, Richard F Schlenk, Markus Schaich, et al.
Page
of 24
Search research articles
Search
Showing results (191-200 of 240) with videos related to
Sort By:
Page
of 24
Bone Marrow Transplantation
|
November 13, 2021
Correction to: Salvage treatment with plerixafor in poor mobilizing allogeneic stem cell donors: results of a prospective phase II-trial
Kristina Hölig, Helmuth Schmidt, Gero Hütter, et al.
Frontiers in Immunology
|
October 31, 2022
Perturbations of mesenchymal stromal cells after allogeneic hematopoietic cell transplantation predispose for bone marrow graft-versus-host-disease
Thomas Krüger, Rebekka Wehner, Maik Herbig, et al.
The Lancet. Haematology
|
March 19, 2018
Long-term efficacy of reduced-intensity versus myeloablative conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: retrospective follow-up of an open-label, randomised phase 3 trial
Frederick Fasslrinner, Johannes Schetelig, Andreas Burchert, et al.
Lancet (London, England)
|
December 7, 2010
Complete remission and early death after intensive chemotherapy in patients aged 60 years or older with acute myeloid leukaemia: a web-based application for prediction of outcomes
Utz Krug, Christoph Röllig, Anja Koschmieder, et al.
Bone Marrow Transplantation
|
October 8, 2020
Salvage treatment with plerixafor in poor mobilizing allogeneic stem cell donors: results of a prospective phase II-trial
Kristina Hölig, Helmuth Schmidt, Gero Hütter, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
November 10, 2015
Allogeneic Stem Cell Transplantation Improves Survival in Patients with Acute Myeloid Leukemia Characterized by a High Allelic Ratio of Mutant FLT3-ITD
Anthony D Ho, Johannes Schetelig, Tilmann Bochtler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 2013
High-dose cytarabine consolidation with or without additional amsacrine and mitoxantrone in acute myeloid leukemia: results of the prospective randomized AML2003 trial
Markus Schaich, Stefani Parmentier, Michael Kramer, et al.
Nature Astronomy
|
July 26, 2022
Discovery of a radio emitting neutron star with an ultra-long spin period of 76 seconds
Manisha Caleb, Ian Heywood, Kaustubh Rajwade, et al.
The Journal of Clinical Investigation
|
September 13, 2022
Immune dysfunction signatures predict outcomes and define checkpoint blockade-unresponsive microenvironments in acute myeloid leukemia
Sergio Rutella, Jayakumar Vadakekolathu, Francesco Mazziotta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 12, 2012
Acute Myeloid Leukemia (AML): different treatment strategies versus a common standard arm--combined prospective analysis by the German AML Intergroup
Thomas Büchner, Richard F Schlenk, Markus Schaich, et al.
Page
of 24